AACR
April 14, 2023 - April 19, 2023
Orange County Convention Center, Orlando, Florida | Booth 1427
Learn More
From CRISPR technology and single-cell spatial analysis to targeting KRAS-G12C and BRAF, WuXi AppTec is proud to be presenting 10 posters at this year's AACR annual meeting. As a global leader in supporting cancer drug discovery programs, WuXi AppTec offers a comprehensive platform of services, including drug-resistant CDX/PDX tumor models, antibody-drug conjugates, and CAR-T cell therapy.
Our scientists welcome the opportunity to meet with you during this prestigious conference. Visit us at Booth 1427 to get your oncology-related questions answered by one of our experts. For a dedicated meeting time, you can also pre-arrange a one-on-one discussion by completing this brief form, or contacting us at discoveryservices@wuxiapptec.com
WuXi AppTec Poster Presentations:
| Abstract #4984: Integrated platform enables KRAS-targeted drug discovery Tuesday, April 18th, 1:30 PM – 5:00 PM ET, Poster Section 16 |
| Abstract #3638: Integrated single-cell and spatial analysis reveal the mechanism of KRASG12C inhibitor AMG510 in HSC-humanized NOG-EXL model Tuesday, April 18th, 9:00 AM – 12:30 PM ET, Poster Section 5 |
| Abstract #1842: Safety assessment and pharmacodynamic evaluation of therapeutic cytokines in non-human primates Monday, April 17th, 9:00 AM – 12:30 PM ET, Poster Section 24 |
| Abstract #4988: Therapeutic potential of polatuzumab vedotin for the treatment of diffuse large B-cell lymphoma Tuesday, April 18th, 1:30 PM – 5:00 PM ET, Poster Section 17 |
| Abstract #4673: A tailored platform enables BRAF-targeted drug discovery and precision medicine Tuesday, April 18th, 1:30 PM – 5:00 PM ET, Poster Section 6 |
| Abstract #3971: Developing cancer cell based in vitro and in vivo models with CRISPR-mediated knock-in technology for anti-tumor drug discovery Tuesday, April 18th, 9:00 AM – 12:30 PM ET, Poster Section 18 |
| Abstract #4464: Comparison of two DTH models for T cell-mediated immunity in preclinical screening Tuesday, April 18th, 9:00 AM – 12:30 PM ET, Poster Section 41 |
| Abstract #5130: Multi-plex cytokine profiling for mice on Bleomycin-induced systemic sclerosis model Tuesday, April 18th, 1:30 PM – 5:00 PM ET, Poster Section 23 |
| Abstract #1380: Blocking autophagy ameliorates the severity of ConA-induced autoimmune hepatitis in mice Monday, April 17th, 9:00 AM – 12:30 PM ET, Poster Section 8 |
| Abstract #257: CDX model-based genome-scale CRISPR KO screens for modulators of KRAS (G12C) inhibitor sensitivity Sunday, April 16th, 1:30 PM – 5:00 PM ET, Poster Section 9 |
